(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

KIDNEYCARE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

KIDNEYCARE

ST13

US500000088611726

Class

5, 44

Filing

88611726

Registration

6217846

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

12/09/2025

Trademark type

Combined

Nice classes

5, 44

Filing date

09/10/2019

Registration date

12/08/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/08/2020

Last transaction

12/09/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/18/2019

First use in commerce

09/18/2019

Drawing code

3

Owner type

03

Owner location

Brisbane, CA

Examiner

ELLIOTT,LASHAWNDA E

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a gray square on the lower left side and a red square on the upper right side, and the gray wording "KIDNEYCARE" to the right of the design. All instances of the color white in the mark represents background and/or transparent areas only and is not claimed as features of the mark.

Holders and representatives

Holders

CareDx, Inc.

Representatives

Theresa Conduah Alston & Bird LLP

Technical classification

Nice Classes

Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic testing kits comprised of medical diagnostic reagents and assays for organ transplant surveillanceincluding damagerejectiontolerance

Class 44

Medical diagnostic servicesgene expression testing to determine immune response; medical diagnostic servicescell-free DNA testing for medical purposes; medical diagnostic testingdonor-specific cell-free DNA testing to determine immune response and organ transplant rejection or tolerance; medical diagnostic testing servicesblood-based testing to determine immune response and organ transplant rejection or tolerance

Publications

History of USPTO decisions and trademark events.

29 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/08/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/27/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/27/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/27/2024

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

12/18/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/18/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/18/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/18/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

12/08/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/03/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/02/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/02/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/02/2020

IUAF

USE AMENDMENT FILED

09/17/2020

EISU

TEAS STATEMENT OF USE RECEIVED

09/17/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/17/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/21/2020

PUBO

PUBLISHED FOR OPPOSITION

01/21/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/01/2020

ALIE

ASSIGNED TO LIE

12/16/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/12/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

12/12/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/12/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

12/12/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/12/2019

DOCK

ASSIGNED TO EXAMINER

12/11/2019

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/20/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/19/2019

NWAP

NEW APPLICATION ENTERED

09/13/2019

Continuous trademark protection

Get notified about every new filing that threatens KIDNEYCARE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.